ArticleMolecular biotechnology2025

Pan-Cancer Analysis and Experimental Validation of CEND1 as a Prognostic and Immune Infiltration-Associated Biomarker for Gliomas.

Jinyang Ma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.